ESR1 and neoplasm: We aimed to evaluate the distribution of clinical parameters and tumor characteristics between patients with combined high ERβ + negative ERα expression, considered to be the best prognostic group, and those with combined low ERβ + positive ERα expression, considered to be the worst prognostic group.